Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) Population

NCT01425814 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: LAS100977
DRUG: LAS100977
DRUG: LAS100977
DRUG: LAS100977
DRUG: Reference
DRUG: Placebo

Sponsor

AstraZeneca